E-ERAD-432 - Identification and molecular charaterization of new tumor suppressor genes on prostate cancer

Status
Released on 17 February 2016, last updated on 17 May 2016
Organism
Homo Sapien
Samples (48)
Protocols (2)
Description
Transposon mutagenesis screens in mice has allowed us the identification of new tumor suppressor genes in cancer. To further explore the mechanistic role of these genes at the molecular level, we decided to study the transcriptome of human immortalized and cancer cells which underwent siRNA-mediated silencing of these tumor suppressors. This data is part of a pre-publication release. For information on the proper use of pre-publication data shared by the Wellcome Trust Sanger Institute (including details of any publication moratoria), please see http://www.sanger.ac.uk/datasharing/
Experiment type
RNA-seq of coding RNA 
Contact
MINSEQE
Exp. designProtocolsVariablesProcessedSeq. reads
Files
Investigation descriptionE-ERAD-432.idf.txt
Sample and data relationshipE-ERAD-432.sdrf.txt
Links